These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6802938)

  • 21. Measurements of whole body retention of diphosphonate and other indices of bone metabolism in 125 normals: dependency on age, sex and glomerular filtration.
    Hyldstrup L; McNair P; Finn Jensen G; Borg Mogensen N; Transbøl I
    Scand J Clin Lab Invest; 1984 Dec; 44(8):673-8. PubMed ID: 6528212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.
    Hyldstrup L; McNair P; Ring P; Henriksen O
    Eur J Nucl Med; 1987; 12(12):585-8. PubMed ID: 3107991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A longitudinal study of bone-related biochemical changes at the menopause.
    Nordin BE; WIshart JM; Clifton PM; McArthur R; Scopacasa F; Need AG; Morris HA; O'Loughlin PD; Horowitz M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):123-30. PubMed ID: 15212654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GFR-corrected 24-hour whole body retention of diphosphonate: an improved index of bone metabolism.
    Hyldstrup L; McNair P; Transbøl I
    Scand J Clin Lab Invest; 1988 Jun; 48(4):341-5. PubMed ID: 3238315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males.
    Molloi S; Mazess R; Bendsen H; Wilson M
    Calcif Tissue Int; 1989 May; 44(5):322-9. PubMed ID: 2496903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone turnover determined by urinary excretion of [99mTc]diphosphonate in the prediction of postmenopausal bone loss.
    Thomsen K; Rødbro P; Christiansen C
    Bone Miner; 1987 Apr; 2(2):125-31. PubMed ID: 3504724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
    Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
    Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of metabolic activity in bone tissue in rats using 24-hour whole-body retention of 99mTc-diphosphonate].
    Kapitola J; Kobos L; Jahoda I; Vilimovská D
    Sb Lek; 1986 Jan; 88(1):13-6. PubMed ID: 3952433
    [No Abstract]   [Full Text] [Related]  

  • 29. Generalized skeletal response to 99mtechnetium methylene diphosphonate in rheumatoid arthritis.
    Helfgott S; Rosenthall L; Esdaile J; Tannenbaum H
    J Rheumatol; 1982; 9(6):939-41. PubMed ID: 6219221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of 24-hour whole-body retention of Tc-99mMDP with a thyroid uptake probe: quantitative assessment of metabolic and metastatic bone diseases.
    Seto H; Futatsuya R; Ihara F; Kamei T; Furumoto N; Ishizaki Y; Hada M; Kakishita M
    Radiat Med; 1984; 2(2):87-92. PubMed ID: 6240671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal pharmacokinetics of 99mTc-diphosphonate after intravenous administration.
    Castronovo FP
    Biopharm Drug Dispos; 1981; 2(3):283-9. PubMed ID: 7295885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative distribution of diphosphonate between bone and soft tissue at 4 and 24 hours: concise communication.
    Smith ML; Martin W; Fogelman I; Bessent RG
    J Nucl Med; 1983 Mar; 24(3):208-11. PubMed ID: 6402571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera.
    Martin W; Fogelman I; Bessent RG
    J Nucl Med; 1981 Jun; 22(6):542-5. PubMed ID: 6785399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short term whole body retention in relation to rate of bone resorption and cartilage degradation after intravenous bisphosphonate (pamidronate) in rheumatoid arthritis.
    Cremers SC; Lodder MC; Den Hartigh J; Vermeij P; Van Pelt P; Lems WF; Papapoulos SE; Dijkmans BA
    J Rheumatol; 2004 Sep; 31(9):1732-7. PubMed ID: 15338492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of 24 hour whole body retention of 99Tcm-diphosphonate by a single thyroid probe.
    Lang P; Büll U
    Nucl Med Commun; 1984 Oct; 5(10):627-32. PubMed ID: 6442403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism.
    Kosowicz J; El Ali Z; Ziemnicka K; Sowinski J
    J Clin Densitom; 2007; 10(3):332-9. PubMed ID: 17470407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
    Fogelman I; Bessent RG; Turner JG; Citrin DL; Boyle IT; Greig WR
    J Nucl Med; 1978 Mar; 19(3):270-5. PubMed ID: 564941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of synthetic steroid (Org OD 14): effect on skeletal metabolism by 24-h whole-body retention of diphosphonate.
    Fogelman I; Bessent RG; Smith ML; Hart DM; Lindsay R
    Maturitas; 1981 Dec; 3(3-4):265-9. PubMed ID: 6801438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a potential therapeutic value of copper and zinc for osteoporosis?
    Lowe NM; Lowe NM; Fraser WD; Jackson MJ
    Proc Nutr Soc; 2002 May; 61(2):181-5. PubMed ID: 12133199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.